Dr. David Lowe is Senior Vice President Biologics at Peptone and has more than 25 years of experience discovering and developing biologic therapeutics. After earning a PhD at Cambridge, he joined Cambridge Antibody Technology and later AstraZeneca, developing protein engineering platforms and programs spanning antibodies, peptides, recombinant proteins, mRNA, and AAV gene therapies.
Senior Vice President Biologics